- Apple intensifies succession planning for CEO Tim Cook, FT reports Reuters
- Apple intensifies succession planning for CEO Tim Cook Financial Times
- Apple’s Succession Strategy: Preparing for Leadership Change Devdiscourse
- Apple weighs post-Cook era as report points to John Ternus as likely next chief Telegraph India
- Meet John Ternus: The 50-year-old Apple engineer who could replace Tim Cook as the next Apple CEO financialexpress.com
Category: 3. Business
-
Apple intensifies succession planning for CEO Tim Cook, FT reports – Reuters
-
Assessing Valuation After Strong Q3 Revenue and Profit Growth
Melco Resorts & Entertainment (MLCO) released its latest quarterly earnings, showing a clear jump in both revenue and net income compared to the same period last year. The company’s improving profitability has caught investor attention.
See our latest analysis for Melco Resorts & Entertainment.
The upbeat earnings report appears to have powered strong momentum in Melco Resorts & Entertainment’s share price. The stock has climbed 11% over the past month and surged 64% so far this year. Although the five-year total shareholder return is still well below its prior highs, recent gains suggest a shift in sentiment as the company’s fundamentals improve and confidence returns.
If Melco’s sharp turnaround has you thinking bigger, now is a perfect moment to broaden your search and discover fast growing stocks with high insider ownership
Given the sharp rally and recent earnings surprise, investors are now weighing whether Melco Resorts & Entertainment remains undervalued or if the market has already factored in its future growth potential. Is there still a buying opportunity, or has optimism run ahead of reality?
At a price-to-earnings (P/E) ratio of 34x, Melco Resorts & Entertainment’s valuation is notably higher than the industry average. This makes the stock look expensive at the latest close of $9.06 despite recent growth.
The P/E ratio measures how much investors are willing to pay per dollar of company earnings. It is a widely watched indicator for hospitality companies because profits can fluctuate significantly in this sector due to shifting consumer demand and economic cycles.
While Melco’s P/E ratio is higher than the U.S. Hospitality industry average of 21.4x, it is still beneath the peer group average of 40.2x. This suggests the market is pricing in robust future earnings growth and a turnaround in profitability, but perhaps not to the same degree as its closest rivals. The fair price-to-earnings ratio is estimated at 33.3x, not far from Melco’s current multiple, which could mean future re-rating potential is limited.
Explore the SWS fair ratio for Melco Resorts & Entertainment
Result: Price-to-Earnings of 34x (OVERVALUED)
However, slower revenue growth or a sudden dip in profitability could challenge the optimism that has been driving Melco Resorts & Entertainment’s recent share price rally.
Find out about the key risks to this Melco Resorts & Entertainment narrative.
Looking beyond the price-to-earnings ratio, our DCF model estimates Melco Resorts & Entertainment’s fair value at $21.84, which is 58.5% above its current share price. This approach suggests the market may be underestimating Melco’s long-term cash flow prospects. Is the stock an overlooked opportunity?
Continue Reading
-
Assessing Current Valuation as Shares Show Steady Progress
EQT (OM:EQT) caught investor attention after its recent market move, with shares showing moderate shifts across the month and quarter. This opens up new discussions about how EQT is currently valued in the market.
See our latest analysis for EQT.
This year, EQT’s share price showed steady progress, up 8.3% year-to-date, while its one-year total shareholder return climbed to an impressive 15.5%. Momentum has been building, which suggests renewed investor confidence as market sentiment improves.
If you’re looking to spot more companies where growth and management conviction go hand in hand, consider broadening your outlook and discover fast growing stocks with high insider ownership
Given these recent shifts, the key question remains: is EQT still undervalued enough to warrant new investment? Alternatively, has the market already factored in the company’s growth prospects, leaving little room for further upside?
With EQT’s most popular narrative estimating a fair value above the recent closing price of SEK 335, the market may be discounting stronger long-term growth potential than currently reflected. This section highlights the narrative’s core driver and invites you to explore the full valuation assumptions.
The firm’s global diversification, especially its push into fast-growing Asian markets (e.g., India, Japan) and the U.S., positions it to benefit as more capital is funneled into private assets in these regions. This supports sustained AUM growth and higher future earnings.
Read the complete narrative.
Curious about what propels EQT’s target valuation far beyond the current price? The story hinges on a massive expansion plan, ambitious margin forecasts, and bold earnings projections. Want to discover which growth bets could make or break this outlook? Unlock the full details and see the financial reasoning behind this bullish case.
Result: Fair Value of $372.65 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, slower fundraising growth or execution challenges from expansion could quickly dampen EQT’s bullish outlook if these issues are not managed successfully.
Find out about the key risks to this EQT narrative.
Looking at valuation through the lens of the price-to-earnings ratio offers a different perspective. EQT trades at 42.5x earnings, which is much higher than the Swedish industry average of 25.3x and the fair ratio of 30.9x. This steep premium suggests greater valuation risk if market expectations change. Is this optimism justified, or are investors paying too much for growth?
Continue Reading
-
US jury says Apple must pay Masimo $634 million in smartwatch patent case – Reuters
- US jury says Apple must pay Masimo $634 million in smartwatch patent case Reuters
- Apple’s Redesigned Watch Faces Trade Commission Import Review Bloomberg Law News
- Apple under USITC investigation again over Apple Watch blood oxygen sensing AppleInsider
- Masimo wins $634M verdict in Apple spat as ITC considers import ban MassDevice
- ITC To Scrutinize Redesigned Apple Watch In Masimo IP Fight Law360
Continue Reading
-
Republic of Colombia – Announcement of Offer to Purchase Old Bonds
BOGOTA, Colombia, Nov. 14, 2025 /PRNewswire/ — Colombia announced today the commencement of an offer to purchase for cash (the “Offer“) from each registered holder or beneficial owner (each, a “Holder” and, collectively, the “Holders“) the outstanding bonds of the series set forth in the table below (collectively, the “Old Bonds“), such that the maximum amount to be paid for the Old Bonds validly tendered and accepted for purchase pursuant to the Offer, not including interest accrued and unpaid thereon, is to be determined by Colombia in its sole discretion (such amount for each series, the “Maximum Purchase Amount“). The terms and conditions of the Offer are set forth in the offer document, dated November 14, 2025 (the “Offer Document“), including the borrowing or issuance of debt and receipt of funds by Colombia (the “Financing Condition“).
Subject to the Financing Condition, the Offer is not conditioned upon any minimum participation of any series of the Old Bonds.
The purchase price to be paid per U.S.$1,000, €1,000, Ps. 1,000 principal amount of each series of Old Bonds, as applicable, that are accepted pursuant to the Offer will be an amount equal to the fixed price indicated in the table below (such amount for each series, the “Purchase Price“). In addition to the Purchase Price, Holders whose Old Bonds are accepted for purchase in the Offer will also receive any accrued and unpaid interest from, and including, the last interest payment date for such Old Bonds up to, but excluding, the Settlement Date (as defined below) (the “Accrued Interest“). If the aggregate Purchase Price for all validly tendered Old Bonds of a series would exceed the Maximum Purchase Amount, then Colombia will, in its sole discretion, apply a proration factor to the Tenders (as defined below).
Old Bonds
Old Bonds
Outstanding Principal
Amount as of November
14, 2025Security Identifier
Fixed Purchase Price(1)
3.875% Global Bonds due 2026 (the “EUR
2026 Global Bonds“)€634,893,000
ISIN: XS1385239006
Common Code: 138523900
€ 1,005.71
9.850% Global TES Bonds due 2027 (the
“COP 2027 Global Bonds“, and together
with the EUR 2026 Global Bonds, the
“Non-U.S. Dollar Bonds“)Ps.1,924,515,000,000
ISIN: XS0306322065
Common Code: 030632206
Ps. 1,000.00
3.875% Global Bonds due 2027
U.S.$1,740,144,000
CUSIP: 195325DL6
ISIN: US195325DL65
$1,000.00
4.500% Global Bonds due 2029
U.S.$2,000,000,000
CUSIP: 195325DP7
ISIN: US195325DP79
$1,000.00
3.000% Global Bonds due 2030
U.S.$1,542,968,000
CUSIP: 195325DR3
ISIN: US195325DR36
$918.75
7.375% Global Bonds due 2030
U.S.$1,900,000,000
CUSIP: 195325 ER2
ISIN: US195325ER27
$1,086.25
10.375% Global Bonds due 2033
U.S.$340,511,000
CUSIP: 195325BB0
ISIN: US195325BB02
$1,277.50
8.000% Global Bonds due 2033
U.S.$1,624,241,000
CUSIP: 195325EF8
ISIN: US195325EF88
$1,127.50
7.500% Global Bonds due 2034
U.S.$2,200,000,000
CUSIP: 195325EG6
ISIN: US195325EG61
$1,087.50
8.500% Global Bonds due 2035
U.S.$1,900,000,000
CUSIP: 195325 ES0
ISIN: US195325ES00
$1,160.00
8.000% Global Bonds due 2035
U.S.$1,900,000,000
CUSIP: 195325EL5
ISIN: US195325EL56
$1,117.50
7.750% Global Bonds due 2036
U.S.$2,000,000,000
CUSIP: 195325EP6
ISIN: US195325EP60
$1,090.00
7.375% Global Bonds due 2037
U.S.$1,818,400,000
CUSIP: 195325BK0
ISIN: US195325BK01
$1,066.25
6.125% Global Bonds due 2041
U.S.$2,500,000,000
CUSIP:195325BM6
ISIN: US195325BM66
$928.75
5.000% Global Bonds due 2045
U.S.$3,670,948,000
CUSIP: 105325CU7
ISIN: US105325CU73
$787.50
8.750% Global Bonds due 2053
U.S.$1,900,000,000
CUSIP: 195325EM3
ISIN: US195325EM30
$1,192.50
8.375% Global Bonds due 2054 (together
with the other U.S. dollar denominated
bonds listed above, the “U.S. Dollar
Bonds“)U.S.$1,640,000,000
CUSIP: 195325EQ4
ISIN: US195325EQ44
$1,147.50
(1)
Per $1,000 for the U.S. Dollar Bonds per €1,000 for the EUR 2026 Global Bonds and per Ps.1,000 for the COP 2027 Global Bonds.
(2)
In the case of the COP 2027 Global Bonds, the Purchase Price and related accrued interest will be paid in U.S. dollars, in an amount determined by converting the Purchase Price and related accrued interest to U.S. dollars at a currency exchange rate equal to the “Representative Market Rate” in effect as of 2:00 p.m., New York City time, on the U.S. business day prior to the Non-U.S. Dollar Bonds Tender Period Expiration Time as calculated and published by the Financial Superintendency of Colombia, and which is available on Bloomberg by typing “COP TRM Curncy
HP ” or at the Financial Superintendency’s website at https://www.superfinanciera.gov.co/publicaciones/60819/informes-y-cifrascifrasestablecimientos-de-creditoinformacion-periodicadiariatasa-de-cambio-representativa-del-mercado-trm-60819/. Old Bonds may be tendered only in principal amounts equal to the minimum authorized denomination and integral multiples thereof, as set forth below for each series of Old Bonds (the “Minimum Denomination“). Holders who tender less than all of their Old Bonds must continue to hold Old Bonds in at least the Minimum Denomination.
In determining the amount of Old Bonds to be purchased against the Maximum Purchase Amount and available for purchases pursuant to the Offer, the aggregate U.S. dollar-equivalent purchase price of (i) the EUR 2026 Global Bonds shall be calculated at the exchange rate for the Euro to U.S. Dollar, as of 2:00 p.m., New York City time, on the U.S. business day prior to the Non-U.S. Dollar Bonds Tender Period Expiration Time (as defined below), as reported on Bloomberg screen page “FXIP” under the heading “FX Rate vs. USD” (or, if such screen is unavailable, a generally recognized source for currency quotations selected by Colombia with quotes as of a time as close as reasonably possible to the aforementioned), and (ii) the COP 2027 Global Bonds, shall be calculated at the exchange rate equal to the “Representative Market Rate” in effect as of 2:00 p.m., New York City time, on the U.S. business day prior to the Non-U.S. Dollar Bonds Tender Period Expiration Time as calculated and published by the Financial Superintendency of Colombia, and which is available on Bloomberg by typing “COP TRM Curncy
HP ” or at the Financial Superintendency’s website at https://www.superfinanciera.gov.co/publicaciones/60819/informes-y-cifrascifrasestablecimientos-de-creditoinformacion-periodicadiariatasa-de-cambio-representativa-del-mercado-trm-60819/. Old Bonds
Minimum Authorized Denominations
3.875% Global Bonds due 2026
€100,000 and integral multiples of €1,000 in excess thereof
9.850% Global TES Bonds due 2027
Ps. 5,000,000 and integral multiples of Ps. 1,000,000 in excess thereof
3.875% Global Bonds due 2027
U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof
4.500% Global Bonds due 2029
U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof
7.375% Global Bonds due 2030
U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof
3.000% Global Bonds due 2030
U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof
10.375% Global Bonds due 2033
U.S.$1,000 and integral multiples of U.S.$1,000 in excess thereof
8.000% Global Bonds due 2033
U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof
7.500% Global Bonds due 2034
U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof
8.500% Global Bond due 2035
U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof
8.000% Global Bonds due 2035
U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof
7.750% Global Bonds due 2036
U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof
7.375% Global Bonds due 2037
U.S.$100,000 and integral multiples of U.S.$1,000 in excess thereof
6.125% Global Bonds due 2041
U.S.$100,000 and integral multiples of U.S.$1,000 in excess thereof
5.000% Global Bonds due 2045
U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof
8.750% Global Bonds due 2053
U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof
8.375% Global Bonds due 2054
U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof
Colombia reserves the right, in its sole discretion, not to accept any valid orders to tender any series of Old Bonds in accordance with the terms and conditions of the Offer (“Tenders“), subject to applicable law, to increase or decrease the Purchase Price for any series of the Old Bonds, or to terminate the Offer for any reason. In the event of a termination of the Offer, the tendered Old Bonds will be returned to the tendering Holder.
If Colombia accepts all or a portion of a Holder’s Tender, the Holder will be entitled to receive for such Old Bonds the applicable Purchase Price plus Accrued Interest, which will be paid on the Settlement Date (as defined below), if the conditions of the Offer are met.
The Offer commenced on Friday, November 14, 2025. Unless extended or earlier terminated in Colombia’s sole discretion, the Offer will expire at (i) 5:00 p.m., New York City time, on Wednesday, November 19, 2025 for U.S. Dollar Bonds (the “U.S. Dollar Bonds Tender Period Expiration Time“) and (ii) 5:00 p.m., New York City time, on Friday, November 21, 2025 for Non-U.S. Dollar Bonds (the “Non-U.S. Dollar Bonds Tender Period Expiration Time“). In the event that the Offer to purchase U.S. Dollar Bonds or Non-U.S. Dollar Bonds is extended or earlier terminated, the terms “U.S. Dollar Bonds Tender Period Expiration Time” and “Non-U.S. Dollar Bonds Tender Period Expiration Time” shall mean the time and date on which such Offer, as so extended or earlier terminated, shall expire. The settlement of the Offer is scheduled to occur on Wednesday, November 26, 2025 (the “Settlement Date“).
The Old Bonds are held in book-entry form through either the facilities of The Depository Trust Company (“DTC“) or held in book-entry form through the facilities of Clearstream Banking, société anonyme (“Clearstream“), Euroclear Bank S.A./N.V., as operator of the Euroclear System (“Euroclear,” and together with DTC and Clearstream referred to herein as a “Covered Clearing System” and, collectively, as the “Covered Clearing Systems“). In the event of a termination of the Offer, the Old Bonds tendered pursuant to the Offer will be credited to the Holder through the relevant Covered Clearing System.
You are advised to consult with the broker, dealer, bank, custodian, trust company, or other nominee through which you hold your Old Bonds as to the deadlines by which such intermediary would require receipt of instruction from you to participate in the Offer in accordance with the terms and conditions of the Offer as described in the Offer Document in order to meet the deadlines set forth in the Offer Document. The deadlines set by DTC, Euroclear, Clearstream, or any such intermediary for the submission of Old Bonds may be earlier than the relevant deadlines specified in the Offer Document. The acceptance of any Tenders forwarded to DTC from Euroclear or Clearstream after the Non-U.S. Dollar Tender Period Expiration Time or U.S. Dollar Tender Period Expiration Time, as the case may be, will be in the sole discretion of Colombia.
The complete terms and conditions of the Offer are set forth in the Offer Document, together with any amendments or supplements thereto, which Holders are urged to read carefully before making any decision with respect to the Offer.
Global Bondholder Services Corporation is serving as the tender agent and the information agent in connection with the Offer (the “Tender and Information Agent“), and the Offer Document may be downloaded from the Tender and Information Agent’s website https://www.gbsc-usa.com/colombia/ or obtained from the Tender and Information Agent at the contact below:
Contact information:
Global Bondholder Services Corporation
Attention: Corporate Actions
65 Broadway – Suite 404
New York, New York 10006
Attn: Corporate Actions
Banks and Brokers call: +1 (212) 430-3774
Toll free +1 (855) 654-2015
E-mail: [email protected]
, or from the Dealer Managers.
The dealer managers (the “Dealer Managers“) for the Offer are:
Goldman Sachs & Co. LLC
Attention: Liability Management
200 West Street, New York
New York 10282-2198
Toll Free: +1 (800) 828-3182
Collect: +1 (212) 357-1452
J.P. Morgan Securities LLC
Attention: Latin America Debt
Capital Markets270 Park Avenue
New York, New York 10017
United States of America
Toll Free: +1 (866) 846-2874
Collect: +1 (212) 834-7279
Santander U.S. Capital Markets LLC
Attention: Liability Management
437 Madison Avenue
New York, New York 10022
United States of America
U.S. Toll Free: (855) 404-3636
U.S. Collect: (212) 350-0660
Email (U.S.): [email protected]
Email (Europe) (Banco Santander, S.A.):
[email protected]
Questions regarding the Offer may be directed to and the Offer Document may be obtained from the Dealer Managers at the above contact information.
Republic of Colombia
Ministerio de Hacienda y Crédito Público
Dirección General de Crédito Público y Tesoro Nacional
Carrera 8, No. 6C-38, Piso 1
Bogotá D.C., ColombiaFor press inquiries:
Contact: Javier Andrés Cuéllar Sánchez
E-mail: [email protected]
Call: (57) 601 3811700 Ext 3126Important Notice
This announcement is not an offer to purchase or a solicitation of an offer to sell the Old Bonds. The Offer will be made only by and pursuant to the terms of the Offer Document, as may be amended or supplemented from time to time.
The distribution of materials relating to the Offer, and the transactions contemplated by the Offer, may be restricted by law in certain jurisdictions. The Offer is made only in those jurisdictions where it is legal to do so. The Offer is void in all jurisdictions where they are prohibited. If materials relating to the Offer come into your possession, you are required to inform yourself of and to observe all of these restrictions. Each person accepting the Offer shall be deemed to have represented, warranted and agreed (in respect of itself and any person for whom it is acting) that it is not a person to whom it is unlawful to make the Offer pursuant to the Offer Document, it has not distributed or forwarded the Offer Document or any other documents or materials relating to the Offer to any such person, and that it has complied with all laws and regulations applicable to it for purposes of participating in the Offer. Neither Colombia nor any Dealer Manager accepts any responsibility for any violation by any person of the restrictions applicable in any jurisdiction.
The materials relating to the Offer do not constitute, and may not be used in connection with, an offer or solicitation in any place where offers or solicitations are not permitted by law. If a jurisdiction requires that the Offer be made by a licensed broker or dealer and a Dealer Manager or any affiliate of a Dealer Manager is a licensed broker or dealer in that jurisdiction, the Offer, as the case may be, shall be deemed to be made by any Dealer Manager or such affiliate in that jurisdiction. Owners who may lawfully participate in the Offer in accordance with the terms thereof are referred to as “holders.”
SOURCE Republic of Colombia
Continue Reading
-
RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders – Business Wire
- RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders Business Wire
- RPTX: Acquisition by XenoTherapeutics announced; $11.6M revenue and $3.3M net income for the quarter TradingView
- Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders Morningstar
- XenoTherapeutics to acquire Repare Therapeutics for $1.82 per share Investing.com
- Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc. Investing News Network
Continue Reading
-
How Tencent’s (TCEHY) AI Strength And Carbon Credit Plans Shape Its Growth Outlook
Tencent Holdings Ltd. (OTC:TCEHY) is among the most fantastic stocks every investor should pay attention to. In a November 7 report, Bloomberg said that sustained momentum in AI development should help the company to report strong earnings for the third quarter. Moreover, results from Tencent and its peers were expected to indicate progress and standing in the AI landscape amid the rising rivalry with the U.S.
On November 13, the company reported better-than-expected results with revenue surging 15% year-over-year to RMB 192.9 billion, and operating profit rising 19% to RMB 63.6 billion. Both of these came in ahead of the consensus of RMB 189.2 billion and RMB 58.01 billion, as per LSEG data, respectively. As was expected, investments in AI supported the topline growth with strong performance in gaming and marketing services, driven by AI-powered gaming engagement and ad targeting. Operating margin also improved by 100 basis points YoY to 33% (on IFRS basis). With strong topline growth and improved margins, EPS rose 20% to RMB 6.779.
Another development that is gaining traction amid the ongoing COP30 climate summit in Brazil is Tencent’s preparation for an alliance of carbon credit buyers. On Wednesday, November 12, Bloomberg reported that the company is in discussions with mostly Asian firms from the manufacturing, technology, and consumer sectors to create a consortium that can buy carbon credits.
Ella Wang, a senior program director at Tencent, said that the company needs to purchase spot and forward carbon credits to offset its emissions and to expedite its target to become carbon neutral. The alliance described above would create more demand. Ella further elaborated:
“We believe it would send a signal to the market and encourage more potential suppliers, especially in the Global South countries.” She also said, “Such an alliance would benefit the companies in many respects, including helping with compliance and technology adoption”.
Tencent Holdings Ltd. (OTC:TCEHY) is a leading Chinese multinational technology conglomerate specializing in internet-related services, entertainment, and artificial intelligence.
While we acknowledge the potential of TCEHY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 13 Best Stocks to Buy According to Citadel LLC and Goldman Sachs Defense Stocks: Top 10 Stocks to Buy.
Disclosure: None. This article is originally published at Insider Monkey.
Continue Reading
-
Apple intensifies succession planning for CEO Tim Cook
Unlock the Editor’s Digest for free
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
Apple is stepping up its succession planning efforts, as it prepares for Tim Cook to step down as chief executive as soon as next year.
Several people familiar with discussions inside the tech group told the Financial Times that its board and senior executives have recently intensified preparations for Cook to hand over the reins at the $4tn company after more than 14 years.
John Ternus, Apple’s senior vice-president of hardware engineering, is widely seen as Cook’s most likely successor, although no final decisions have been made, these people said.
People close to Apple say the long-planned transition is not related to the company’s current performance, ahead of what is expected to be a blockbuster end-of-year sales period for the iPhone.
Apple declined to comment.
The company is unlikely to name a new CEO before its next earnings report in late January, which covers the critical holiday period.
An announcement early in the year would give its new leadership team time to settle in ahead of its big annual keynote events, its developer conference in June and its iPhone launch in September, the people said.
These people said that although preparations have intensified, the timing of any announcement could change.
Cook, Apple’s former operations chief who turned 65 this month, has led the company since 2011 when he took over the role from its co-founder Steve Jobs, who died months later. During Cook’s tenure, the Big Tech group’s market capitalisation has surged from about $350bn in 2011 to $4tn today.
Apple’s shares are trading close to an all-time high after strong results last month, although its stock-price rise of roughly 12 per cent this year lags behind its Big Tech rivals Alphabet, Nvidia and Microsoft, whose valuations have been propelled by Wall Street’s exuberance about artificial intelligence.
Apple has had a number of high-profile changes this year among its top executive team. Longtime Cook confidante, chief financial officer Luca Maestri, stepped back from his role at the start of this year. Jeff Williams, a Cook protégé, announced he was stepping down as chief operating officer in July.
Appointing Ternus would put an executive from the hardware side of the company back in charge at the iPhone maker at a time when Apple has struggled to break into new product categories and keep up with its Silicon Valley rivals in AI.
Cook has voiced his preference for an internal candidate to be chosen as his replacement, saying the company has “very detailed succession plans”.
“I love it there and I can’t envision my life without being there so I’ll be there a while,” he told singer Dua Lipa on her podcast in November 2023.
Continue Reading
-
Why Ascletis Pharma (SEHK:1672) Is Up 45.4% After Unveiling New Obesity Drug Data and US IND Plans
-
Ascletis Pharma announced new preclinical and Phase Ib clinical results for its portfolio of next-generation obesity drug candidates, including ASC36, ASC35, and ASC30, developed using its proprietary AISBDD and ULAP technologies.
-
A key highlight is the plan to submit a US Investigational New Drug Application in 2026 for a co-formulated monthly therapy that showed greater weight reduction in animal models compared to existing treatments.
-
We’ll explore how Ascletis Pharma’s advancement toward a US IND submission for its obesity treatment candidates could reshape its investment narrative.
AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10b in market cap – there’s still time to get in early.
For investors considering Ascletis Pharma, the core belief hinges on the company’s ability to break into the high-growth obesity treatment market with its new-generation drug candidates. The recent disclosure of strong preclinical and Phase Ib data for ASC36, ASC35, and ASC30, along with a planned US IND application for a co-formulated monthly obesity therapy, marks a potentially significant catalyst that could refresh sentiment and drive near-term share price momentum. This news adds clear visibility to the clinical pipeline, which has repeatedly faced skepticism due to historic unprofitability and regulatory hurdles. While the obesity portfolio’s progress could accelerate prospects and broaden Ascletis’ market appeal, key risks remain, especially related to clinical trial outcomes and the heavy investment demands required before potential commercialisation. Materially, these developments could shift attention from past earnings volatility toward future pipeline milestones as primary value drivers.
On the flip side, regulatory outcomes and patent risks remain critical concerns for shareholders. Upon reviewing our latest valuation report, Ascletis Pharma’s share price might be too optimistic.
SEHK:1672 Earnings & Revenue Growth as at Nov 2025 The Simply Wall St Community offered one fair value estimate before this latest news event, suggesting very little variation in opinions at that time. While clinical trial advancements have improved pipeline visibility, actual commercial success depends on regulatory approvals and market uptake. Explore other views that may broaden your perspective on what could shape the company’s future.
Explore another fair value estimate on Ascletis Pharma – why the stock might be worth less than half the current price!
Continue Reading
-
-
Valuation Insights After Earnings Beat and New Wireless Power Partnership
MDA Space (TSX:MDA) is making headlines after two major updates for investors: robust earnings for the quarter and year to date, along with a new partnership to advance wireless power systems for use in space.
See our latest analysis for MDA Space.
The share price has had a turbulent ride this year, with a sharp dip in recent months weighing on sentiment. Positive earnings and partnership news made headlines during this period. While the year-to-date share price return stands at -21.87%, long-term investors have still pocketed a 238.3% total shareholder return over the past three years. This points to significant gains for those who have stayed the course.
Curious what else is happening in the sector? You can explore other aerospace and defense innovators with strong momentum by checking out See the full list for free.
MDA Space’s recent results and high-profile partnership have caught investor attention, but with shares still well below analyst targets and strong revenue gains, is this a bargain opportunity or is future growth already priced in?
According to IndusyHoldings, the narrative puts MDA Space’s fair value at CA$44.08, nearly double the recent close. This sets the stage for an ambitious financial outlook.
MDA Space can benefit greatly from the tailwind of the industry as they offer a wide product range that includes LEO and MEO satellites, space robots and space rovers.
Read the complete narrative.
What’s the growth blueprint fueling that target price? The narrative’s secret sauce lies in bold projections about future revenue and profit margins. Want to know which key financial figures put this company in the spotlight? The full story breaks down the ambitious numbers that build this valuation case. Read on to see what’s driving it.
Result: Fair Value of $44.08 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, heavy reliance on government contracts and potential Artemis delays could quickly overturn the optimistic outlook presented by current projections.
Find out about the key risks to this MDA Space narrative.
If you want to dig deeper or see things differently, you can analyze the data for yourself and shape your own view in just a few minutes. Do it your way
A great starting point for your MDA Space research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.
Outsmart the ordinary by tapping into opportunities others might miss. Make your next move count by finding well-positioned stocks with just a few quick clicks below.
Continue Reading